SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-000689
Filing Date
2020-01-10
Accepted
2020-01-10 06:40:31
Documents
7
Period of Report
2020-01-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K derm-8k_20200110.htm 8-K 66287
2 EX-2.1 derm-ex21_6.htm EX-2.1 700138
3 EX-10.1 derm-ex101_37.htm EX-10.1 99052
4 EX-10.2 derm-ex102_38.htm EX-10.2 108039
5 EX-99.1 derm-ex991_271.htm EX-99.1 36282
6 GRAPHIC gf5himwnhbul000002.jpg GRAPHIC 2955
7 GRAPHIC gf5himwnhbul000001.jpg GRAPHIC 3184
  Complete submission text file 0001564590-20-000689.txt   1019726
Mailing Address 275 MIDDLEFIELD ROAD SUITE 150 MENLO PARK CA 94025
Business Address 275 MIDDLEFIELD ROAD SUITE 150 MENLO PARK CA 94025 650 421 7200
Dermira, Inc. (Filer) CIK: 0001557883 (see all company filings)

IRS No.: 273267680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36668 | Film No.: 20519422
SIC: 2834 Pharmaceutical Preparations